×

Access all guidelines and regulatory updates on

QuriousRI
×

Access all guidelines and regulatory updates on

QuriousRI

Artixio

Singapore Regulatory Affairs

Regulatory Affairs Consulting Services in Singapore

We offer an end-to-end regulatory affairs solutions in Singapore to support healthcare product registration and approvals with a clear, strategic approach.

Our Regulatory Affairs Consulting Services in Singapore

Singapore has emerged as a key regulatory gateway for healthcare companies targeting Southeast Asia. Singapore’s healthcare market is robust and growing tremendously with a projected revenue of US$13.03 billion by 2029, an annual growth rate of 7.10% from 2025 to 2029.

The Health Sciences Authority (HSA), under the Ministry of Health, plays a central role to regulate therapeutic products, medical devices, health products, and cosmetics. For foreign manufacturers, getting a product approval is more than just submitting paperwork as it requires a local partner and an understanding of the process. Working with the best regulatory affairs company like Artixio can help you navigate the process with confidence.

Regulatory Authorities in Singapore

Authority Scope
Health Sciences Authority (HSA) Responsible for evaluation and registration of drugs, devices, biologics, and cosmetics.
Ministry of Health (MoH) Responsible for healthcare policies, licensing of healthcare institutions and professionals.

Regulatory Affairs Process in Singapore

The product registration regulatory process in Singapore involves the following six key stages. While timelines and formats vary across product categories, the below reflects the general regulatory lifecycle:

Regulatory Affairs Process in Singapore
Step 1 - Product Classification
Before submission, the applicant must identify the correct product category to determine the documentation required.
Incorrect classification may lead to delays or outright rejection.
Step 2 - Appoint a Local Authorized Representative (LAR)
Foreign companies require a designated Singapore-based Local Authorized Representative (LAR) to manage the product application with HSA. They also hold the marketing authorization and must have a valid import license, where applicable.
Step 3 - Dossier Preparation
Depending on product type, the following dossier formats must be followed:
Documents must be submitted in English.
Step 4 - Application Submission & Evaluation
Submissions are made via HSA’s PRISM portal. Evaluation timelines vary by the regulatory pathway:
Evaluation Route Eligibility Timeline
Full Evaluation No prior approvals ~270 working days
Abridged Evaluation Approved by 1 reference agency (e.g. USFDA, EMA, PMDA) ~180 working days
Verification Evaluation Approved by 2+ reference agencies ~60 working days
Immediate Registration Class A medical devices ~10 working days
Step 5 - Product Approval and Licensing
Once approved, products receive:
Step 6 - Post-Market Obligations
Companies are responsible for:
HSA conducts periodic inspections and may suspend or revoke licenses in case of non-compliance.

Why Choose Artixio For RA Services In Singapore

Compliance consulting services company
products approved across ASEAN markets
Compliance consulting services company
ISO 9001:2015 certified documentation workflows
Compliance consulting services company
End to End product lifecycle support and renewals
Compliance consulting services company
Strong LAR partnerships and on-ground support
Compliance consulting services company
PRISM e-submission readiness and technical dossier audits

Are you launching your product in Singapore? Artixio helps you reduce regulatory risks and get your product registered efficiently in Singapore. Our team ensures the regulatory compliance with ASEAN CTD format, facilitating smooth market entry and sustained product success. Talk to our Singapore regulatory affairs consultant today. Let’s plan your successful market entry!

FAQs

Does HSA accept US FDA or EMA approvals to simplify the review?
Yes, products approved by reference agencies can qualify for abridged or verification routes, significantly reducing review timelines.
No, each product can only be registered under one license holder in Singapore.
Renewals must be submitted at least before six months expiry. Supporting stability and quality data may be required.
It is not always required as bridging studies may be waived if foreign clinical data is sufficient and applicable to the local population.

Still Have Questions ?

Get expert answers tailored to your needs.

Specialized Registration
Services Across Multiple Industries

Regulatory and compliance expert – Artixio

Pharmaceuticals

Medical device regulatory services – Artixio

MedTech

Cosmetics regulatory consulting – Artixio

Cosmetics

Nutrition regulatory consulting – Artixio

Nutrition

Biologics regulatory consulting – Artixio

Biologics

Veterinary regulatory consulting – Artixio

Veterinary

Expert Regulatory Services To Streamline Compliance

GxP Compliance Regulatory monitoring services
Regulatory Intelligence & Strategy
Medical & Technical Writing
Publishing & Submission
Product Registration
Investigation New Drug Application (IND)
New Drug Application (NDA)
Post Approval Lifecycle Maintenance
Artwork and Label Review
Ad Promo Review

Regulatory Affairs Across Multiple Countries

India Artixio – Regulatory affairs consulting expert

India

Singapore Artixio – Regulatory affairs consulting expert

Singapore

Mexico Artixio – Regulatory affairs consulting expert

Mexico

Brazil Artixio – Regulatory affairs consulting expert

Brazil

Vietnam Artixio – Regulatory affairs consulting expert

Vietnam

Malaysia Artixio – Regulatory affairs consulting expert

Malaysia

Argentina Artixio – Regulatory affairs consulting expert

Argentina

Colombia Artixio – Regulatory affairs consulting expert

Colombia

Taiwan Artixio – Regulatory affairs consulting expert

Taiwan

China Artixio – Regulatory affairs consulting expert

China

Europe Artixio – Regulatory affairs consulting expert

European

Thailand Artixio – Regulatory affairs consulting expert

Thailand

Indonesia Artixio – Regulatory affairs consulting expert

Indonesia

Philippines Artixio – Regulatory affairs consulting expert

Philippines

USA Artixio – Regulatory affairs consulting expert

USA

Japan Artixio – Regulatory affairs consulting expert

Japan

Qatar

South Korea

Insights from Artixio - Tips & Articles

HSA Guidance on Class 2 CTGTP Registration in Singapore

HSA Guidance on Class

Advanced medicines, such as cell, gene, and tissue-engineered therapies, are revolutionizing modern medicine. In...

February 24, 2026
HSA Singapore Investigational Product Management Guidance

HSA Singapore Investigational Product

For locally registered products in Singapore, the management of investigational product (IP) for clinical...

February 23, 2026
Strategic Criteria for Selecting a Regulatory Consultant in Thailand

Strategic Criteria for Selecting

All industries in Thailand, including cosmetics, food, medical devices, and nutrition, develop very fast,...

January 28, 2026

Get in touch

×